Answers are in the Blood: cfDNA to Enhance Precision Medicine for Breast Cancer

Clin Cancer Res. 2021 Apr 9:clincanres.0353.2021. doi: 10.1158/1078-0432.CCR-21-0353. Online ahead of print.ABSTRACTIdentification of biomarkers to drive treatment using cell free DNA allows dynamic and safe assessment of tumor biology representing an important advance adding to tissue based genotyping. Caution must be exercised interpreting commercial matching information as validation is often lacking, and true matching is feasible in a minority of patients.PMID:33837007 | DOI:10.1158/1078-0432.CCR-21-0353
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research